Cyclobutanes in Small-Molecule Drug Candidates

被引:116
|
作者
van der Kolk, Marnix R. [1 ]
Janssen, Mathilde A. C. H. [1 ]
Rutjes, Floris P. J. T. [1 ]
Blanco-Ania, Daniel [1 ]
机构
[1] Radboud Univ Nijmegen, Inst Mol & Mat, Heyendaalseweg 135, NL-6526 AJ Nijmegen, Netherlands
基金
荷兰研究理事会;
关键词
Cyclobutanes; strained carbocycles; conformational restriction; pharmacophores; isosteres; HISTAMINE H-3 RECEPTOR; GLYCOGEN-SYNTHASE KINASE-3; APOLIPOPROTEIN-E; GLUCOKINASE ACTIVATORS; BIOLOGICAL EVALUATION; HISTONE MODIFICATIONS; SELECTIVE INHIBITORS; INDAZOLE DERIVATIVES; STRUCTURAL BASIS; POTENTIAL ROLE;
D O I
10.1002/cmdc.202200020
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cyclobutanes are increasingly used in medicinal chemistry in the search for relevant biological properties. Important characteristics of the cyclobutane ring include its unique puckered structure, longer C-C bond lengths, increased C-C pi-character and relative chemical inertness for a highly strained carbocycle. This review will focus on contributions of cyclobutane rings in drug candidates to arrive at favorable properties. Cyclobutanes have been employed for improving multiple factors such as preventing cis/trans-isomerization by replacing alkenes, replacing larger cyclic systems, increasing metabolic stability, directing key pharmacophore groups, inducing conformational restriction, reducing planarity, as aryl isostere and filling hydrophobic pockets.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] Applications of small-molecule combinatorial chemistry to drug discovery
    Patel, DV
    Gordon, EM
    DRUG DISCOVERY TODAY, 1996, 1 (04) : 134 - 144
  • [22] A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
    Stover, CK
    Warrener, P
    VanDevanter, DR
    Sherman, DR
    Arain, TM
    Langhorne, MH
    Anderson, SW
    Towell, JA
    Yuan, Y
    McMurray, DN
    Kreiswirth, BN
    Barry, CE
    Baker, WR
    NATURE, 2000, 405 (6789) : 962 - 966
  • [23] AI in small-molecule drug discovery: a coming wave?
    Jayatunga, Madura K. P.
    Xie, Wen
    Ruder, Ludwig
    Schulze, Ulrik
    Meier, Christoph
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (03) : 174 - 175
  • [24] Small-molecule drug conjugates for theranostics of prostate cancer
    Hao, Guiyang
    Kumar, Amit
    Mastren, Tara
    Wang, Bin
    Hsieh, Jer-Tsong
    Sun, Xiankai
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [25] RNA as a small-molecule drug target - Letter to the editor
    Czarnik, AW
    DRUG DISCOVERY TODAY, 2000, 5 (03) : 94 - 94
  • [26] A Small-Molecule Drug for the Self-Checking of Mitophagy
    Gao, Yanan
    Bai, Qingjie
    Ren, Youxiao
    Shao, Xintian
    Zhang, Mengrui
    Wu, Luling
    Lewis, Simon E.
    James, Tony D.
    Chen, Xiaoyuan
    Chen, Qixin
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025, 64 (10)
  • [27] Computational Workflow to Design Novel Vaccine Candidates and Small-Molecule Therapeutics for Schistosomiasis
    Balogun, Emmanuel Oluwadare
    Joseph, Gideon Ibrahim
    Olabode, Samuel Charles
    Dayaso, Naziru Abdulkadir
    Danazumi, Ammar Usman
    Bashford-Rogers, Rachael
    Mckerrow, James H.
    Jeelani, Ghulam
    Caffrey, Conor R.
    PATHOGENS, 2024, 13 (10):
  • [28] Thiosemicarbazide Derivatives Targeting Human TopoIIα and IDO-1 as Small-Molecule Drug Candidates for Breast Cancer Treatment
    Kapron, Barbara
    Czarnomysy, Robert
    Radomska, Dominika
    Bielawski, Krzysztof
    Plech, Tomasz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [29] SPIDR: small-molecule peptide-influenced drug repurposing
    Matthew D. King
    Thomas Long
    Daniel L. Pfalmer
    Timothy L. Andersen
    Owen M. McDougal
    BMC Bioinformatics, 19
  • [30] Small-molecule microarrays
    Weitzman J.B.
    Genome Biology, 3 (1)